Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIMEx
NCT03449524Phase 2Terminated
- Sponsor
- Complexa Therapeutics
- Start
- Aug 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of 10-nitro-oleic acid in pulmonary arterial hypertension (PAH), sponsored by Complexa Therapeutics. Started Aug 2018; status: terminated.
02
Drugs
10-nitro-oleic acid
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT03449524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03449524.